Stefan W. Krause
University Hospital of Erlangen
120 papers found
Refreshing results…
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
UploadReal-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
UploadOn its way to primetime ‐ artificial intelligence in flow cytometry diagnostics
UploadMissing publications? Search for publications with a matching author name.